Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Minichromosome maintenance proteins (Mcms) play an important role in the initial stages of DNA replication in eukaryotic cells. The Mcm protein family is a class of highly conserved proteins with the same central domain. Mcm1 and Mcm10 are not part of this family of proteins, but are functionally similar to the Mcm family of proteins, which also play an important role in the replication of eukaryotic DNA. Mcm10 is a key replication factor found in the S-stage progression-deficient budding yeast. Comparing Mcm10 homologues, they were found to be structurally and functionally conserved, with three common structures, including the N-terminal domain (NTD) and the conserved internal domain (internal domain), ID) and C-terminal domain (CTD).
The role of Mcm10 in The Initiation of Replication
Mcm10 plays a role in the initiation of DNA replication mainly by promoting the unwinding of DNA double helix and triggering the initiation program, but the specific molecular mechanism is still unclear. Mcm10 is an important replication factor involved in the activation of the Cdc45-Mcm2-7-GINS complex (CMG) helicase, which may be related to the ability of Mcm10 to bind single-stranded DNA or double-stranded DNA. Mcm10 itself does not have enzymatic activity. Some studies have shown that Mcm10 can interact with protein factors such as Pol-α and proliferating cell nuclear antigen (PCNA) on the replication fork to support the scaffolding and participate in DNA unwinding and synthesis, thereby promoting DNA elongation.

Figure 1. Model of Mcm10 function. (Langston, et al. 2017)
Mcm10 is loaded onto DNA in the G1 phase after replication initiation "licensing", and promotes helicase activation and DNA polymerase loading at the beginning of S phase. Prior to loading of Mcm10, the functional replication helicase (CMG dimer) is in an inactive state, and then the stimulation by the complex formed by the binding of Mcm10 to CMG induces activation of the helicase. The expression of Mcm10 in human cells is related to the cell cycle. The study found that the Mcm10 mutant was unable to maintain chromosome integrity and showed defects in S-phase development. If Mcm10 is degraded before the start of S phase, the cells will not be able to complete the transition from G1 phase to S phase, and the DNA replication process will not be successfully initiated. All of the above findings suggest that Mcm10 is involved in the cellular activities of S phase.
Mcm10 and Genome Stabilization
Deletion of the cell Mcm10 results in replication stress, which affects the stability of the replication protein on the DNA strand. Mcm10 disruption in mice significantly reduces DNA synthesis and increases DNA damage; in human cells, knockdown of Mcm10 induces DNA damage, G-phase arrest, and apoptosis. Screening of whole-genome small interfering RNA (siRNA) revealed that knockout of Mcm10 resulted in an increase in the early marker γ-H2AX of DNA double-strand breaks (DSBs). In an independent siRNA screening experiment, it was found that in order to cope with DNA damage caused by Mcm10 knockdown, the level of intracellular DSBs repair marker (p53-binding protein 1, 53BP1) was elevated. The above research data shows that Mcm10 is essential for preventing replication stress and DSBs from accumulating.
Genetic analysis of yeast has demonstrated that the Mcm10 mutant relies on the checkpoint signal factor Mec1 (mitosis entry checkpoint 1) and the radiation sensitive factor Rad53 (radiation sensitive 53). In the case of high replication pressure, Rad53 is hyperactivated, hindering the S phase process. The Mcm10 mutant exhibits loss of adaptability after binding to gene mutations such as checkpoint signaling genes and human capillary ataxia-related genes. After Mcm10 injury, its interaction with genes involved in repairing the repetitive replication fork problem Decreased. Moderate Mcm10 deletion in budding yeast mainly leads to defects in the progression of the replication fork, revealing that Mcm10 maintains genome stability in a number of ways.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.